Table:
begin	end	state
1	23	cytoplasmic
24	42	transmembrane
43	54	non-cytoplasmic
55	74	transmembrane
75	88	cytoplasmic
89	108	transmembrane
109	113	non-cytoplasmic
114	136	transmembrane
137	147	cytoplasmic
148	171	transmembrane
172	181	non-cytoplasmic
182	203	transmembrane
204	250	cytoplasmic
251	272	transmembrane
273	291	non-cytoplasmic
292	310	transmembrane
311	316	cytoplasmic
317	333	transmembrane
334	338	non-cytoplasmic
339	360	transmembrane
361	370	cytoplasmic
371	394	transmembrane
395	406	non-cytoplasmic
407	425	transmembrane
426	465	cytoplasmic

Input:
>Pf6N2E2_691
LNNVTDSTHDSTLALAAAKVKRHVLPLVVVMFIVNYIDRVNIGFVRSHLETDLGIGAAAY
GLGAGLFFVGYALFEVPSNMLLQRYGARAWLTRIMFTWGAAAMAMAFVRGETSFYVLRFI
LGAAEAGFFPGIIYYFTQWLPANERGKAMAIFLSGSAIASVISGPVSGALLHISGMGLHG
WQWMFLIEGFASIVLCGFVWFWLQSHPSQAKWLSSEEKTVLIAAIAEEQRAREAAQVIKP
SIFKLLADRQIALFCFIYFSIALTIYGATFWLPSMIKKMGNLGDFQVGLLNSIPWIISII
AMYGFAALAGKWKFQQAWVAVTLVVAAFGMFMSTTGGPIFAFVAICFAAIGFKAASALFW
PIPQGYLDARIAAAVIALINSIGNLGGFVAPTAFGFLEQTTGSIEGGLYGLAATSLVAAV
VIFFARTAPKRDTPNSLSGRPEAVAEASQSQTSQALKPGPSGAAV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server